Evidence map›Paper›PMID 42795652›Full record

ArticleMicroorganisms2026

Paired In Vitro Susceptibility of Cefiderocol and Colistin in Colistin-Resistant, Extensively Drug-Resistant Gram-Negative Bacilli: A Single-Centre, MIC-Based Analysis of 236 Clinical Isolates.

Elena Hogea, Nicolae Ciprian Pilut, Felix Bratosin, Andra-Nicole Rusnac, Oana Plavitu, Livia Stanga, Horia Silviu Branea

Abstract read
In one paragraph

Article in Microorganisms, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Elena HogeaDiscipline of Microbiology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.ORCID 0009-0008-8805-2046
Nicolae Ciprian PilutDepartment of Dermatology, Victor Babes University of Medicine and Pharmacy Timisoara, Eftimie Murgu Square 2, 300041 Timisoara, Romania.ORCID 0009-0006-9681-8289
Felix BratosinDiscipline of Infectious Diseases, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.ORCID 0000-0003-4711-4315
Andra-Nicole RusnacMicrobiology Laboratory, "Pius Brinzeu" County Clinical Emergency Hospital, 300723 Timisoara, Romania.
Oana PlavituClinical Hospital of Infectious Diseases and Pulmonology "Dr. Victor Babes", 300310 Timisoara, Romania.
Livia StangaDiscipline of Microbiology, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.
Horia Silviu BraneaDepartment of Internal Medicine I-Medical Semiotics II, Victor Babes University of Medicine and Pharmacy, 300041 Timisoara, Romania.ORCID 0000-0002-7896-1253

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Extensively drug-resistant (XDR) Gram-negative bacilli increasingly exhaust therapeutic options, leaving colistin and cefiderocol as last-resort agents. We assessed whether cefiderocol retains in vitro activity against colistin-resistant isolates, without inferring clinical efficacy. We analysed 236 non-duplicate XDR Gram-negative isolates from 220 patients. Cefiderocol and colistin MICs were determined via reference broth microdilution with EUCAST-required quality control (iron-depleted broth for cefiderocol;

Indexed as

bacterialcefiderocolcolistindrug resistanceGram-negative bacterial infectionsmicrobial sensitivity testsmultiple

Identifiers

PMID42795652
PMCPMC13609237

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.